| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of thalidomide in patients with platinum-refractory germ-cell tumours
|
Rick, O.
|
|
2006
|
42 |
12 |
p. 1775-1779
5 p.
|
artikel
|
| 2 |
Adjuvant trastuzumab therapy for HER2-overexpressing breast cancer: What we know and what we still need to learn
|
Piccart-Gebhart, Martine J.
|
|
2006
|
42 |
12 |
p. 1715-1719
5 p.
|
artikel
|
| 3 |
A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours
|
Izquierdo, Miguel Angel
|
|
2006
|
42 |
12 |
p. 1789-1796
8 p.
|
artikel
|
| 4 |
Calendar
|
|
|
2006
|
42 |
12 |
p. I-II
nvt p.
|
artikel
|
| 5 |
(CA)n Microsatellite polymorphism of ERBB-1 in breast cancer
|
Wełnicka-Jaśkiewicz, Marzena
|
|
2006
|
42 |
12 |
p. 1698-1701
4 p.
|
artikel
|
| 6 |
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus
|
Duran, I.
|
|
2006
|
42 |
12 |
p. 1875-1880
6 p.
|
artikel
|
| 7 |
Clinical factors associated with fatigue in haematologic cancer patients receiving stem-cell transplantation
|
Prieto, Jesús M.
|
|
2006
|
42 |
12 |
p. 1749-1755
7 p.
|
artikel
|
| 8 |
Clinical molecular imaging with positron emission tomography
|
Saleem, Azeem
|
|
2006
|
42 |
12 |
p. 1720-1727
8 p.
|
artikel
|
| 9 |
Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing’s sarcoma
|
Kreuter, Michael
|
|
2006
|
42 |
12 |
p. 1904-1911
8 p.
|
artikel
|
| 10 |
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)
|
von Minckwitz, Gunter
|
|
2006
|
42 |
12 |
p. 1780-1788
9 p.
|
artikel
|
| 11 |
Editorial board
|
|
|
2006
|
42 |
12 |
p. ii-
1 p.
|
artikel
|
| 12 |
EJC NEWS, ISSUE 12, 2006
|
|
|
2006
|
42 |
12 |
p. 1693-1697
5 p.
|
artikel
|
| 13 |
Establishing content validity of the oral assessment guide in children and young people
|
Gibson, Faith
|
|
2006
|
42 |
12 |
p. 1817-1825
9 p.
|
artikel
|
| 14 |
Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study
|
Khoo, Kei Siong
|
|
2006
|
42 |
12 |
p. 1797-1806
10 p.
|
artikel
|
| 15 |
Information provision for patients by breast cancer teams about the side-effects of hormone treatments
|
McGurk, Rhona
|
|
2006
|
42 |
12 |
p. 1760-1767
8 p.
|
artikel
|
| 16 |
Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients
|
Dünne, A.A.
|
|
2006
|
42 |
12 |
p. 1863-1868
6 p.
|
artikel
|
| 17 |
Molecular prognostic markers in resectable colorectal liver metastases: A systematic review
|
Neal, C.P.
|
|
2006
|
42 |
12 |
p. 1728-1743
16 p.
|
artikel
|
| 18 |
Multilocus loss of heterozygosity allelotypes identify a genetic pathway associated with progression from low to high stage disease in neuroblastoma
|
Chughtai, Shaheen A.
|
|
2006
|
42 |
12 |
p. 1826-1834
9 p.
|
artikel
|
| 19 |
Past chlamydial infection is not associated with primary fallopian tube carcinoma
|
Riska, A.
|
|
2006
|
42 |
12 |
p. 1835-1838
4 p.
|
artikel
|
| 20 |
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours
|
de Jonge, M.J.A.
|
|
2006
|
42 |
12 |
p. 1768-1774
7 p.
|
artikel
|
| 21 |
Prediction of peritoneal metastasis in advanced gastric cancer by gene expression profiling of the primary site
|
Motoori, Masaaki
|
|
2006
|
42 |
12 |
p. 1897-1903
7 p.
|
artikel
|
| 22 |
Prognostic factors for progression of childhood optic pathway glioma: A systematic review
|
Opocher, Enrico
|
|
2006
|
42 |
12 |
p. 1807-1816
10 p.
|
artikel
|
| 23 |
Prostate cancer specific mortality in the Florence screening pilot study cohort 1992–1993
|
Ciatto, Stefano
|
|
2006
|
42 |
12 |
p. 1858-1862
5 p.
|
artikel
|
| 24 |
Re-analysis of the Xq27–Xq28 region suggests a weak association of an X-linked gene with sporadic testicular germ cell tumour without cryptorchidism
|
Lutke Holzik, M.F.
|
|
2006
|
42 |
12 |
p. 1869-1874
6 p.
|
artikel
|
| 25 |
Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: A population based study
|
Arndt, Volker
|
|
2006
|
42 |
12 |
p. 1848-1857
10 p.
|
artikel
|
| 26 |
Role of complementary and alternative medicine in the care of patients with breast cancer: Report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy, December 2004
|
Baum, Michael
|
|
2006
|
42 |
12 |
p. 1702-1710
9 p.
|
artikel
|
| 27 |
The role of complementary and alternative medicine in the management of early breast cancer: Recommendations of the European Society of Mastology (EUSOMA)
|
Baum, Michael
|
|
2006
|
42 |
12 |
p. 1711-1714
4 p.
|
artikel
|
| 28 |
Thyroid metastases from colorectal cancer: The Institut Gustave Roussy experience
|
Lièvre, Astrid
|
|
2006
|
42 |
12 |
p. 1756-1759
4 p.
|
artikel
|
| 29 |
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer
|
Holten-Andersen, Mads Nikolaj
|
|
2006
|
42 |
12 |
p. 1889-1896
8 p.
|
artikel
|
| 30 |
Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands
|
Hoopman, R.
|
|
2006
|
42 |
12 |
p. 1839-1847
9 p.
|
artikel
|
| 31 |
TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells
|
Biroccio, Annamaria
|
|
2006
|
42 |
12 |
p. 1881-1888
8 p.
|
artikel
|
| 32 |
Why don’t cancer patients enter clinical trials? A review
|
Castel, Patrick
|
|
2006
|
42 |
12 |
p. 1744-1748
5 p.
|
artikel
|
Tijdschrift beschrijving